✦ LIBER ✦

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

✍ Scribed by Rich, P.; Sigurgeirsson, B.; Thaci, D.; Ortonne, J.-P.; Paul, C.; Schopf, R.E.; Morita, A.; Roseau, K.; Harfst, E.; Guettner, A.; Machacek, M.; Papavassilis, C.

Book ID: 119826941
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 287 KB
Volume: 168
Category: Article
ISSN: 0007-0963
DOI: 10.1111/bjd.12112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab improves hand, foot and nail

Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial

✍ Paul, C.; Reich, K.; Gottlieb, A.B.; Mrowietz, U.; Philipp, S.; Nakayama, J.; Ha 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Efficacy and safety of secukinumab in th

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Secukinumab efficacy in patients with mo

Secukinumab efficacy in patients with moderate to severe plaque psoriasis and psoriatic arthritis: A phase II, double-blind, randomized trial

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Secukinumab treatment shows a neutral ef

Secukinumab treatment shows a neutral effect on the lipid profile of patients with moderate to severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled, phase II study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Patient-reported outcomes in moderate-to

Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB